Strongyloides hyperinfection: A treatment dilemma

American Journal of the Medical Sciences

Volumn 336, Issue 4, 2008, Pages 358-361

  Miller, Melissa A ^a,b   Church, L W Preston ^a   Salgado, Cassandra D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

HIV; Hyperinfection; Ivermectin; Parenteral; Strongyloides

Indexed keywords

COTRIMOXAZOLE; IVERMECTIN; PREDNISONE;

ABDOMINAL PAIN; ABDOMINAL SCINTISCANNING; ADULT; ARTICLE; BLASTOMYCES; CASE REPORT; CD4 LYMPHOCYTE COUNT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; ESOPHAGOGASTRODUODENOSCOPY; FECES ANALYSIS; HUMAN; IMMUNOCOMPROMISED PATIENT; INJECTION SITE PAIN; INTUSSUSCEPTION; LABORATORY DIAGNOSIS; LAPAROTOMY; MALE; MALNUTRITION; NEMATODIASIS; PHYSICAL EXAMINATION; SINGLE DRUG DOSE; STRONGYLOIDES STERCORALIS; TREATMENT RESPONSE;

EID: 56049116714     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31815cff89     Document Type: Article

References (14)

1. Maguire J. Intestinal nematodes. In: Mandell GL, Bennett JE, Dolin R, editors. Principles, and practice of infectious diseases. Vol 2. 6th ed. Philadelphia, Churchill Livingstone: Elsevier; 2005. 3260-67.
2. Tarr PE, Miele PS, Peregoy KS, et al. Case report: rectal adminstration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003;68: 453-55.
3. Marty F, Lowry C, Rodrigues M. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005;41:e5-e8.
4. Pacanowski J, Santos MD, Roux A. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005;73:122-24.
5. Chiodini PL, Reid AJ, Wiselka MJ, et al. Parenteral ivermectin in Strongyloides hyperinfection. Lancet 2000;355: 43-44.
6. Salluh J, Feres G, Velasco E, et al. Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. Intensive Care Med 2005;31:1292.
7. Genta RM. Strongyloidiasis. In: Guerant R, Walker D, Weller P. editors. Essentials of tropical infectious diseases. Vol 1. New York: Churchill Livingstone; 2001. 464-68.
8. Siddiqui A, Berk S. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001;33:1040-47.
9. Keiser P, Nutman T. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004;17:20817.
10. Carvalho EM, Da Fonseca Porto A. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis. Parasite Immunol 2004;26:487-97.
11. Fardet L, Genereau T, Poirot J-L, et al. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect 2006;54:18-27.
12. Link K, Orenstein R. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis. South Med J 1999; 92:728-31.
13. Concha R, Harrington W, Rogers A. Intestinal strongyloidiasis: recognition, management, and determinants of outcome. J Clin Gastroenterol 2005;39:203-11.
14. Viney ME, Brown M, Omoding NE. Why does HIV infection not lead to disseminated strongyloidiasis? [see comment]. J Infect Dis 2004;190:2175-80.